Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2018: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2017: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000)
Fiscal Year 2016: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
|
Outline of Final Research Achievements |
In the present study, we worked on Smad cofactors in cancer cells, which enable a wide variety of cell responses induced by TGF-β. We identified Olig1 as a Smad cofactor involved in anti-apoptotic function of TGF-β in murine breast cancer cells. We also developed a strategy to screen Smad cofactors that operate in cancer cells and identified two novel Smad cofactors. Furthermore, we found minimal requirements for transcription activation by cooperation of Smad and Smad cofactors.
|